Savara SVRA
NASDAQ SVRA
$5.36 -0.01 (-0.09%)
As of: Sep 4, 2026 · 2:35 PM EDT

Savara (SVRA) Depreciation & Amortization - Total (2016 - 2018)

Analysis

Savara (SVRA) Depreciation & Amortization - Total (2016 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.40 Bn 27.56 Bn - -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -
10 Savara 1.36 Bn 1.36 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 139,000.00
Sep 30, 2018 127,000.00
Jun 30, 2018 153,000.00
Mar 31, 2018 107,000.00
Dec 31, 2017 91,000.00
Sep 30, 2017 91,000.00
Jun 30, 2017 91,000.00
Mar 31, 2017 90,000.00
Dec 31, 2016 90,000.00
Sep 30, 2016 86,000.00
Jun 30, 2016 85,000.00